Ovarian Cancer: Subtle Symptoms, Testing, and Treatment

Ovarian cancer symptoms are often subtle, but persistent bloating, pelvic or abdominal pain, feeling full quickly, and urinary changes should not be ignored. There is no routine screening test recommended for most average-risk women, so symptom awareness and risk assessment are important.
Key Takeaways
- Ovarian cancer symptoms are often subtle, but persistent bloating, pelvic or abdominal pain, feeling full quickly, and urinary changes should not be ignored.
- There is no routine screening test recommended for most average-risk women, so symptom awareness and risk assessment are important.
- Testing may include pelvic examination, ultrasound or CT imaging, tumor marker blood tests such as CA-125, and biopsy or surgical evaluation.
- Treatment often combines surgery and chemotherapy, with targeted therapy, hormone therapy, or immunotherapy used in selected cases.
- People with a strong family history of ovarian, breast, pancreatic, or related cancers may benefit from genetic counseling and testing.
Ovarian cancer can cause vague symptoms such as bloating, pelvic discomfort, and changes in appetite, which is why persistent changes should be discussed with a doctor. Diagnosis usually involves a pelvic exam, imaging, blood tests, and specialist evaluation, while treatment is tailored to cancer type, stage, overall health, and personal goals.
Overview
Ovarian cancer is a cancer that begins in the ovaries, fallopian tubes, or nearby peritoneal tissue. The ovaries are part of the female reproductive system and produce eggs and hormones, but many cancers once called ovarian cancer are now understood to start in the fallopian tube or surrounding tissues. For this reason, doctors often discuss ovarian, fallopian tube, and primary peritoneal cancers together.
Ovarian cancer is not one single disease. The most common group is epithelial ovarian cancer, which develops from cells on the surface of the ovary or related tissues. Less common types include germ cell tumors and stromal tumors, which may occur at different ages and can behave differently. Identifying the type and stage of cancer helps the care team recommend the most appropriate treatment plan.
One reason ovarian cancer can be challenging is that early symptoms may be mild, intermittent, or similar to digestive or urinary problems. However, subtle does not mean invisible. When symptoms are new, frequent, and persistent, a medical evaluation can help clarify the cause and guide timely care.
Subtle Symptoms to Notice

Ovarian cancer symptoms may develop gradually and can be easy to attribute to everyday issues such as indigestion, constipation, stress, or hormonal changes. The key pattern is persistence. Symptoms that occur most days, feel unusual for the person, or worsen over several weeks deserve attention, especially if they do not improve with simple measures.
Common symptoms can include:
- Abdominal bloating, swelling, or a feeling of increased abdominal size
- Pelvic or lower abdominal pain, pressure, or discomfort
- Feeling full quickly, reduced appetite, or difficulty eating normal portions
- More frequent or urgent urination
- Changes in bowel habits, including constipation or diarrhea
- Unexplained fatigue, back pain, or discomfort during sex
- Unexplained weight change or menstrual changes, particularly in premenopausal women
These symptoms are common and often have non-cancer causes. Still, a person should not dismiss them if they are new and persistent. Keeping a short symptom diary, including when symptoms occur and what makes them better or worse, can help the doctor decide which tests are appropriate.
Causes and Risk Factors

Ovarian cancer develops when cells acquire changes that allow them to grow and divide in an uncontrolled way. In many cases, the exact reason this happens is not known. Research has identified several factors that may increase risk, but having a risk factor does not mean a person will develop ovarian cancer, and some people diagnosed have no obvious risk factors.
Risk may be higher with increasing age, especially after menopause, and in people with inherited gene changes such as BRCA1, BRCA2, or genes associated with Lynch syndrome. A personal or family history of ovarian, fallopian tube, primary peritoneal, breast, pancreatic, or certain bowel and uterine cancers can be important. Endometriosis, some reproductive history patterns, and never having been pregnant may also be associated with risk in some people.
Some factors are linked with lower risk, including pregnancy, breastfeeding, and use of certain hormonal contraceptives, although these choices have their own benefits and risks and should be discussed with a clinician. People with a strong family history may benefit from genetic counseling, where a trained professional reviews the family pattern and explains whether genetic testing is appropriate.
Testing and Diagnosis
There is no single test that can reliably diagnose ovarian cancer in all people. Evaluation usually begins with a medical history, review of symptoms, family history, and a pelvic examination. The doctor may assess for abdominal swelling, tenderness, or a pelvic mass, but a normal examination does not always rule out disease, so additional testing may be recommended when symptoms or risk factors are concerning.
Imaging tests are commonly used. A transvaginal ultrasound can look closely at the ovaries and pelvis and may help distinguish simple cysts from more concerning masses. Abdominal or pelvic CT, MRI, or other imaging may be used to understand the size, location, and spread of a suspected tumor. Imaging findings guide the next steps but do not always confirm whether a mass is cancerous.
Blood tests may include tumor markers such as CA-125. CA-125 can be elevated in ovarian cancer, but it can also rise with non-cancer conditions such as endometriosis, fibroids, pelvic infection, liver disease, or menstruation, and it may be normal in some ovarian cancers. For this reason, CA-125 is interpreted alongside symptoms, imaging, menopausal status, and other clinical information. In younger patients or when certain tumor types are suspected, other markers may be ordered.
A confirmed diagnosis usually requires tissue examination by a pathologist. In many cases, this tissue is obtained during surgery performed by a gynecologic oncologist. When cancer has spread or surgery is not the first step, a biopsy from a safe site may be recommended. The pathology report identifies the cancer type and grade, and staging evaluates how far the disease has spread.
Treatment Options
Ovarian cancer treatment is personalized. The care team considers the cancer type, stage, grade, genetic features, the patient’s general health, previous treatments, and personal priorities such as fertility wishes when relevant. A gynecologic oncologist, a specialist in cancers of the female reproductive system, is often central to planning care.
Surgery is a major part of treatment for many patients. The goal may be to remove the tumor and determine the stage, or to remove as much visible cancer as safely possible, a process called cytoreductive or debulking surgery. Depending on the situation, surgery may involve removing one or both ovaries, fallopian tubes, the uterus, nearby tissue, lymph nodes, or affected abdominal tissue. In carefully selected early-stage cases, fertility-sparing surgery may be considered.
Chemotherapy is commonly used, often after surgery and sometimes before surgery if reducing tumor size first is the safer approach. Targeted therapies may be recommended for certain patients, including treatments that act on specific cancer repair pathways or blood vessel growth. Genetic and tumor testing can help determine whether therapies such as PARP inhibitors may be appropriate. Hormone therapy is sometimes used for selected low-grade or stromal tumors, and immunotherapy may be considered in specific molecular situations.
Supportive care is also an important part of treatment. This may include managing nausea, fatigue, pain, nutrition concerns, emotional stress, menopause symptoms, sexual health concerns, and recovery after surgery. Good cancer care addresses both the disease and the person living with it, with regular follow-up to monitor response and adjust the plan when needed.
Prevention, Risk Reduction, and Self-Care
Ovarian cancer cannot always be prevented, but some people can take steps to understand and reduce their risk. Those with a strong family history or known inherited gene change should discuss genetic counseling. For high-risk individuals, doctors may discuss increased monitoring, preventive surgery after childbearing is complete, or other risk-reducing strategies. These decisions are highly personal and should be made with specialist guidance.
For average-risk people, routine screening with ultrasound or CA-125 has not been shown to reliably reduce deaths from ovarian cancer and can lead to false alarms or unnecessary procedures. Instead, awareness of persistent symptoms, regular gynecologic care, and timely evaluation of new concerns are practical steps. People should also keep their doctors informed about family history changes, including cancers diagnosed in relatives.
General health habits cannot guarantee prevention, but they can support overall wellbeing during prevention, diagnosis, or treatment. A balanced diet, regular physical activity when appropriate, not smoking, moderating alcohol, and managing chronic conditions can support recovery and resilience. During cancer treatment, patients should ask their care team before starting supplements or alternative therapies, as some may interfere with prescribed treatments.
When to See a Doctor
A person should arrange a medical appointment if bloating, pelvic or abdominal pain, feeling full quickly, appetite changes, urinary urgency, or bowel changes are new, frequent, and continue for more than a few weeks. Earlier review is especially important if symptoms are worsening, occur after menopause, or are accompanied by unexplained weight loss, unusual bleeding, or a noticeable abdominal swelling.
People with a strong family history of ovarian, breast, pancreatic, uterine, or colorectal cancer should discuss risk assessment even if they feel well. A primary care doctor or gynecologist can review symptoms and risk factors, then refer to a gynecologic oncologist or genetics specialist when appropriate. Seeking medical advice does not mean cancer is likely; it is a way to identify the cause and decide on the right next step.
International patients seeking evaluation or treatment can access multidisciplinary specialists at Acibadem International’s JCI-accredited hospitals, where gynecologic oncology, imaging, pathology, medical oncology, and supportive care teams work together. Wherever care is received, patients should feel comfortable asking about the diagnosis, treatment options, possible side effects, and the goals of each step in the plan.
Frequently asked questions
What are the early warning signs of ovarian cancer?
Early symptoms can be subtle and may include bloating, pelvic or abdominal discomfort, feeling full quickly, and urinary urgency or frequency. These symptoms are often caused by non-cancer conditions, but they should be checked if they are new, persistent, and occur frequently.
Can a Pap smear detect ovarian cancer?
A Pap smear is designed to screen for cervical cancer, not ovarian cancer. It usually does not detect ovarian cancer. If ovarian cancer is suspected, doctors may use pelvic examination, ultrasound, blood tests such as CA-125, imaging, and tissue diagnosis.
Is CA-125 a reliable test for ovarian cancer?
CA-125 can be helpful, especially when interpreted with imaging and clinical findings, but it is not perfect. It may be elevated in non-cancer conditions and may be normal in some people with ovarian cancer. Doctors use it as one part of a broader evaluation rather than as a stand-alone diagnosis.
Who should consider genetic testing for ovarian cancer risk?
Genetic counseling may be recommended for people with a personal or family history of ovarian, fallopian tube, primary peritoneal, breast, pancreatic, or certain colorectal and uterine cancers. A genetics professional can assess the family pattern and explain the benefits, limitations, and possible results of testing.
How is ovarian cancer usually treated?
Treatment often includes surgery and chemotherapy, but the exact plan depends on the type and stage of cancer, overall health, and patient goals. Some patients may also benefit from targeted therapy, hormone therapy, or other treatments based on tumor features and genetic testing.
Can ovarian cancer come back after treatment?
Ovarian cancer can recur in some patients, which is why follow-up visits are important after treatment. Follow-up may include symptom review, physical examination, blood tests, and imaging when needed. If recurrence occurs, additional treatment options may be available depending on the situation.
References
- World Health Organization
- National Cancer Institute
- American Cancer Society
- European Society for Medical Oncology
- American College of Obstetricians and Gynecologists
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Ovarian Cancer in Turkey — costs, top hospitals & a free quote
JCI-accredited · board-certified surgeons · reply within 24h
Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.
Medical Oncology Department
Medical treatment of cancer with chemotherapy, immunotherapy and targeted therapies under a multidisciplinary tumor board.
60 specialists in this unit








